B. Metzler seel. Sohn & Co. AG Cuts Position in Danaher Co. (NYSE:DHR)

B. Metzler seel. Sohn & Co. AG cut its position in Danaher Co. (NYSE:DHR - Free Report) by 9.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 253,119 shares of the conglomerate's stock after selling 24,970 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Danaher were worth $58,072,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher in the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Citigroup reduced their price objective on Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a research report on Thursday, January 30th. The Goldman Sachs Group raised shares of Danaher from a "neutral" rating to a "buy" rating and set a $260.00 price target on the stock in a research report on Friday, March 21st. JPMorgan Chase & Co. cut their price objective on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Jefferies Financial Group decreased their target price on shares of Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a report on Wednesday, January 29th. Finally, Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $278.24.

Danaher Stock Down 2.4 %

Shares of NYSE DHR traded down $4.91 during mid-day trading on Tuesday, hitting $200.09. The company had a trading volume of 3,019,873 shares, compared to its average volume of 3,194,112. The company has a market capitalization of $143.01 billion, a PE ratio of 37.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The business's 50-day simple moving average is $213.02 and its 200 day simple moving average is $235.39. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm posted $2.09 EPS. On average, analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. Danaher's dividend payout ratio (DPR) is presently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.